Navigation Links


PCMA: Medicare Part D 2015 Premiums Remain Flat

7/31/2014
WASHINGTON , July 31, 2014  According to data released today by the Centers for Medicare & Medicaid Services, the 2015 average monthly Medicare Part D premium is expected to remain stable at $32, a figure far lower than was originally projected, the Pharmaceutical Care Management Association (PCMA) said. "The popular Part D program continues to be a bright... [Comments]

Sorrento Announces the Unexpected Death of its Chief Business Officer

7/31/2014
SAN DIEGO , July 31, 2014  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; Sorrento) today announced the death of Mr. Amar Singh , Chief Business Officer and Executive Vice President. Mr. Singh died suddenly and unexpectedly of apparent natural causes on July 30. "Sorrento is deeply saddened and shocked by the loss of our dear friend and colleague. Our immediate thoughts... [Comments]

STAAR Surgical Reports 10% Second Quarter Revenue Growth

7/31/2014
MONROVIA, Calif., July 31, 2014 STAAR Surgical Company (NASDAQ: STAA ) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye today reported revenue for the second quarter ended July 4, 2014 of $20.0 million, a 10% increase over $18.2 million reported for the second quarter of 2013. On a constant currency basis, revenues grew 11% d... [Comments]

IRIDEX Reports 2014 Second Quarter, Six-Month Results

7/31/2014
MOUNTAIN VIEW, Calif., July 31, 2014 IRIDEX Corporation (Nasdaq: IRIX ) today reported financial results for the second quarter and six months ended June 28, 2014.  Revenues were $10.6 million in the second quarter of 2014, up 15% from $9.2 million in the 2013 second quarter and up sequentially from $10.3 million in the first quarter of 2014. Revenues for the first six... [Comments]

RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014

7/31/2014
SAN DIEGO, July 31, 2014  ResMed Inc. (NYSE: RMD ) today announced results for its fourth quarter and for the fiscal year ended June 30, 2014.  Revenue for the quarter was $415.2 million, flat compared to the quarter ended June 30, 2013 (a 1 percent decrease on a constant currency basis). Net income was $87.7 million, an increase of 20 percent compared to the quarter e... [Comments]

Tandem Diabetes Care Reports Second Quarter 2014 Financial Results

7/31/2014
SAN DIEGO, July 31, 2014 Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter ended June 30, 2014. In comparing the second quarter of 2014 to the same period of 2013: Sales grew 86 percent to $10.3 million from $5.5 million t:slim Pump shipments... [Comments]

Xencor Reports Second Quarter 2014 Financial Results

7/31/2014
MONROVIA, Calif., July 31, 2014 Xencor Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today reported financial results for the second quarter ended June 30, 2014 and provided a review of recent business highlights. "In the seco... [Comments]

Pharmacyclics Reports Second Quarter 2014 Results

7/31/2014
SUNNYVALE, Calif., July 31, 2014 Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today reported financial results and recent developments for the quarter ended June 30, 2014. Financial Results for the Six Months and Quarter Ended June 30, 2014 Revenue Total revenue for the quarter ended June 30, 2014 increased to $113.0 million from $54.7 million for the quarter ended Ju... [Comments]

Cepheid to Webcast Upcoming Financial Presentations

7/31/2014
SUNNYVALE, Calif. , July 31, 2014  Cepheid (NASDAQ: CPHD ) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. Wedbush Life Sciences Management Access Conference, New York, NY Wednesday, August 13, 2014 at 9.10 a.m. Eastern Time Baird Health Care Conference, New York, NY Thurs... [Comments]

Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014

7/31/2014
SAN FRANCISCO, July 31, 2014 Nektar Therapeutics (Nasdaq: NKTR ) today reported its financial results for the second quarter ended June 30, 2014. Cash and investments in marketable securities at June 30, 2014 were $301.4 million as compared to $309.1 million at March 31, 2014."The second half of 2014 will be an exciting time for Nektar as we look forward to significant miles... [Comments]

[next]
(Date:7/31/2014)... On October 10, at the Palmer ... Applied Research Foundation, in collaboration with the University ... mesothelioma conference geared to patients and ... to mesothelioma and presented by local and regional ... include imaging, genetics, first-line therapies, surgery, chemotherapy, radiation ...
(Date:7/31/2014)... In today’s world, a good night’s sleep ... and sleep apnea (a medical problem where the airway collapses ... partners of the rest they need to face their daily ... and 20 million people in the United States alone have ... treated; and of those treated, many cannot tolerate their prescribed ...
(Date:7/31/2014)... 31, 2014 Dr. Stewart Shofner ... the first surgeons in the United States to successfully treat ... the smallest medical device ever approved by the FDA. ... recognize the benefits of using a procedure known as Selective ... Shofner and his colleagues now recognize that this procedure is ...
(Date:7/31/2014)... July 31, 2014 The vineyards are lush, ... upcoming harvest. And, to celebrate, folks are gearing up for ... September 6 and 7, 2014 along the Leelanau Peninsula ... optional walk or run through the vineyards start-ing at 9:00 ... Bay. A unique course between rows of grapevines offers an ...
(Date:7/31/2014)... Farmington, NY (PRWEB) July 31, 2014 ... restaurants incorporating Pioneer Millworks’ reclaimed wood to create ... the environment. Their newest location features reclaimed ... the restaurant, with custom selected mixed softwoods flowing ... trusses crafted by Pioneer Millworks’ sister company ...
Breaking Medicine News(10 mins):Health News:October Events: Regional Conference on Mesothelioma in Chicago 2Health News:October Events: Regional Conference on Mesothelioma in Chicago 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 2Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 4Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2Health News:Popular Tavern Restaurant Features Pioneer Millworks’ Reclaimed Wood in New Locations 2
... , SCOTTSDALE, Ariz., Dec. 31 Healthcare ... estate investment trust, announced the completed acquisition of a ... Texas, Corsicana, Texas, and Fort Wayne, Indiana for approximately ... 100% leased to community hospitals that are wholly-owned subsidiaries ...
... It,s a fact: each and every January senior living communities see ... and answers as to how to best care for an aging ... time when adult children come face to face with the increasing ... national leader in senior assisted living and memory care communities, works ...
... LOS ANGELES, Dec. 31 Numbers are not just statistics. Sometimes ... the preceding century when lives became daily body counts in televised ... is certainly not the only organization whose staff have worked ... selfless staffs of all humanitarian groups and those individual human beings ...
... over steroid injections, researchers say , THURSDAY, Dec. 31 ... diabetes-related eye disease, though lasers remain the treatment of ... new research shows. , Researchers from the Johns Hopkins ... had diabetic retinopathy with macular edema either injections of ...
... ... a restaurant chain launched promotion that sold out in 90 minutes using online channel to ... ... closed, there were a handful that took the path less beaten and decided it was ...
... , , MILWAUKEE, Dec. 31 Step to the side of ... a partnership with America,s wellness expert Jillian Michaels to encourage women ... motorcycle. , Michaels, a life-long motorcycle enthusiast and licensed ... Party Month, which features a special promotion that will reward one ...
Cached Medicine News:Health News:Healthcare Trust of America, Inc. Acquires a 92,500 SF Medical Office Portfolio Located in Texas and Indiana 2Health News:Healthcare Trust of America, Inc. Acquires a 92,500 SF Medical Office Portfolio Located in Texas and Indiana 3Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 2Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 3Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 2Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 3Health News:Laser Deemed Best Treatment for Diabetic Retinopathy 2Health News:Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing 2Health News:TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives 2Health News:TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives 3Health News:TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives 4
... the only online source of nationally accredited ... care nurses and other healthcare professionals., ,Radiometers ... you can take them at your convenience. ... is issued upon course completion. The curriculum ...
... links sampler, patient and operator ... data readily available to caregivers ... incorrect patient identification. , ... automatic, the worlds first automatic ...
... POLYGRAM NET™ (PNET) works with the Polygraf™ ... pressure signals from continuous pull-through procedures of ... (LES)., ,Continuous pull-through procedures are usually ... but they may be carried out manually ...
... POLYGRAM NET™ (PNET) works with the ... analyze pressure and EMG signals from ... graphic format. The PNET software and ... or water-perfused manometry catheters as well ...
Medicine Products:
(Date:7/31/2014)... , July 31, 2014 Hovione today ... has successfully passed a pre-approval inspection by the ... carried out by the FDA Consumer Safety Officer, Ms. ... on 21 st July and concluded on the 25 ... with the principles and guidelines of Good Manufacturing Practices (GMP) ...
(Date:7/31/2014)... VIENNA , July 31, 2014 ... New York results of AFF008, a ... disease. PD01A is the first therapy against the protein alpha-synuclein, ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF) ... presented at the press conference on the impact a disease-modifying ...
(Date:7/31/2014)... -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused ... call on Thursday, August 14, 2014, at 4:30 p.m. Eastern ... 30, 2014. Financial results will be issued in a press ... and CEO James LaFrance will host the call, ... Thursday, August 14, 2014 Time: 4:30 p.m. Eastern time (3:30 ...
Breaking Medicine Technology:Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2
... BOSTON, Sept. 13 Cardiovascular disease,kills more women ... is gaining more recognition among physicians and patients, ... make diagnosis and,prognosis of women with heart disease ... What is the Optimal Method of Ischemia,Evaluation in ...
... Bionovo, Inc.,(Nasdaq: BNVI ) today announced ... for,the American Society for Pharmacology and Experimental Therapeutics, ... of,Liquiritigenin, a Bioactive Compound Isolated from the Chinese ... one of the active compounds of MF101, Bionovo,s ...
Cached Medicine Technology:What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3